235 related articles for article (PubMed ID: 17545579)
1. Myc goes global: new tricks for an old oncogene.
Knoepfler PS
Cancer Res; 2007 Jun; 67(11):5061-3. PubMed ID: 17545579
[TBL] [Abstract][Full Text] [Related]
2. Translocations involving c-myc and c-myc function.
Boxer LM; Dang CV
Oncogene; 2001 Sep; 20(40):5595-610. PubMed ID: 11607812
[TBL] [Abstract][Full Text] [Related]
3. Cancer therapeutics: targeting the dark side of Myc.
Ponzielli R; Katz S; Barsyte-Lovejoy D; Penn LZ
Eur J Cancer; 2005 Nov; 41(16):2485-501. PubMed ID: 16243519
[TBL] [Abstract][Full Text] [Related]
4. Acting locally and globally: Myc's ever-expanding roles on chromatin.
Varlakhanova NV; Knoepfler PS
Cancer Res; 2009 Oct; 69(19):7487-90. PubMed ID: 19773445
[TBL] [Abstract][Full Text] [Related]
5. New Myc-anisms for DNA replication and tumorigenesis?
Lebofsky R; Walter JC
Cancer Cell; 2007 Aug; 12(2):102-3. PubMed ID: 17692801
[TBL] [Abstract][Full Text] [Related]
6. c-Myc as a therapeutic target in cancer.
Prochownik EV
Expert Rev Anticancer Ther; 2004 Apr; 4(2):289-302. PubMed ID: 15056059
[TBL] [Abstract][Full Text] [Related]
7. Regulation by c-Myc of ncRNA expression.
Kenneth NS; White RJ
Curr Opin Genet Dev; 2009 Feb; 19(1):38-43. PubMed ID: 19179065
[TBL] [Abstract][Full Text] [Related]
8. The c-myc promoter: still MysterY and challenge.
Wierstra I; Alves J
Adv Cancer Res; 2008; 99():113-333. PubMed ID: 18037408
[TBL] [Abstract][Full Text] [Related]
9. Adenoviral E1A function through Myc.
Chakraborty AA; Tansey WP
Cancer Res; 2009 Jan; 69(1):6-9. PubMed ID: 19117980
[TBL] [Abstract][Full Text] [Related]
10. Mnt takes control as key regulator of the myc/max/mxd network.
Wahlström T; Henriksson M
Adv Cancer Res; 2007; 97():61-80. PubMed ID: 17419941
[TBL] [Abstract][Full Text] [Related]
11. The c-Myc target gene network.
Dang CV; O'Donnell KA; Zeller KI; Nguyen T; Osthus RC; Li F
Semin Cancer Biol; 2006 Aug; 16(4):253-64. PubMed ID: 16904903
[TBL] [Abstract][Full Text] [Related]
12. [File no.47: CMYC].
Soussi T
Bull Cancer; 2001 Nov; 88(11):1053-4. PubMed ID: 11741797
[No Abstract] [Full Text] [Related]
13. The Yin and Yang functions of the Myc oncoprotein in cancer development and as targets for therapy.
Larsson LG; Henriksson MA
Exp Cell Res; 2010 May; 316(8):1429-37. PubMed ID: 20382143
[TBL] [Abstract][Full Text] [Related]
14. Reflecting on 25 years with MYC.
Meyer N; Penn LZ
Nat Rev Cancer; 2008 Dec; 8(12):976-90. PubMed ID: 19029958
[TBL] [Abstract][Full Text] [Related]
15. SNIP1: Myc's new helper in transcriptional activation.
Larsson LG
Mol Cell; 2006 Dec; 24(6):811-2. PubMed ID: 17189184
[TBL] [Abstract][Full Text] [Related]
16. The many roles of c-Myc in apoptosis.
Thompson EB
Annu Rev Physiol; 1998; 60():575-600. PubMed ID: 9558477
[TBL] [Abstract][Full Text] [Related]
17. Myc-mediated transcriptional repression by recruitment of histone deacetylase.
Kurland JF; Tansey WP
Cancer Res; 2008 May; 68(10):3624-9. PubMed ID: 18483244
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic down-regulation of ARF expression is a selection step in immortalization of human fibroblasts by c-Myc.
Benanti JA; Wang ML; Myers HE; Robinson KL; Grandori C; Galloway DA
Mol Cancer Res; 2007 Nov; 5(11):1181-9. PubMed ID: 17982115
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of intestinal polyposis with reduced angiogenesis in ApcMin/+ mice due to decreases in c-Myc expression.
Yekkala K; Baudino TA
Mol Cancer Res; 2007 Dec; 5(12):1296-303. PubMed ID: 18171987
[TBL] [Abstract][Full Text] [Related]
20. Expression of the TAF4b gene is induced by MYC through a non-canonical, but not canonical, E-box which contributes to its specific response to MYC.
Teye K; Okamoto K; Tanaka Y; Umata T; Ohnuma M; Moroi M; Kimura H; Tsuneoka M
Int J Oncol; 2008 Dec; 33(6):1271-80. PubMed ID: 19020761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
